60 likes | 214 Views
North America Injectable Drug Delivery Market report categories North America market estimating and forecasting 2017 by Devices, Formulations, Therapeutics,
E N D
MarketsandMarkets Presents North American Injectable Drug Delivery Market worth $16.6 billion by 2017 http://www.marketsandmarkets.com/Market-Reports/north-america-injectable-drug-delivery-market-1109.html
The "North America Injectables Drug Delivery Market– by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] – Forecasts to 2017 " analyzes and studies the major market drivers, restraints, and opportunities in United States and Canada. Browse >> 130data tables. 28 figures. in-depth TOC on North America Injectables Drug Delivery Market. http://www.marketsandmarkets.com/Market-Reports/north-america-injectable-drug-delivery-market-1109.html Early buyers will receive 10% customization on this report. Request to Download Free PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=1109
The North American injectable drug delivery technologies market was valued at $9.3 billion in 2012 and is poised to grow at a CAGR of 12.3% from 2012 to 2017 to reach $16.6 billion by 2017. The injectable drug delivery technologies market is broadly categorized into two major segments, namely, devices technologies and formulation technologies. Based on product, the injectable drug delivery devices technologies market is further categorized into conventional injection devices, self injection devices, and others (microneedles, nanoneedles and blunt needle injections), while injectable drug delivery formulation technologies market is categorized into conventional drug delivery formulations and novel drug delivery formulations. The report includes company profiles of major players such as Eli Lilly & Co. (U.S.), Sanofi (France), Novo Nordisk A/S (Denmark), Baxter International, Inc. (U.S.), Becton Dickinson & Co. (U.S.), and Hospira Inc. (U.S.). Other prominent players in North America are West Pharmaceutical Services, Inc. (U.S.), Unilife Corporation (U.S.), AntaresPharma, Inc. (U.S.), and Zogenix, Inc. (U.S.), among others. Inquire Before Buying @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=1109
Contact Us Mr. RohanNorth - Dominion Plaza, 17304 Preston Road, Suite 800, Dallas, TX 75252Tel: +1-888-6006-441Email: sales@marketsandmarkets.comMarketsandMarkets Bloghttp://twitter.com/marketsmarkets http://www.linkedin.com/company/marketsandmarkets
About MarketsandMarkets MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. They cover thirteen industry verticals, including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT. We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. http://www.marketsandmarkets.com/Market-Reports/north-america-injectable-drug-delivery-market-1109.html